These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 9696923)

  • 41. Anxiety and addiction: a clinical perspective on comorbidity.
    DuPont RL
    Bull Menninger Clin; 1995; 59(2 Suppl A):A53-72. PubMed ID: 7795572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacotherapy].
    Laux G
    Ther Umsch; 1997 Oct; 54(10):595-9. PubMed ID: 9432751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Drug treatment of anxiety disorders].
    Scholz H; Lhotka R
    Wien Med Wochenschr; 1991; 141(22):526-30. PubMed ID: 1686949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Behavior therapy and antidepressive drugs. What helps with anxiety?].
    Bandelow B
    MMW Fortschr Med; 2002 May; Suppl 2():60-2, 64-5. PubMed ID: 12070854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thinking about stopping treatment for panic disorder.
    DuPont RL
    J Clin Psychiatry; 1990 Dec; 51 Suppl A():38-45. PubMed ID: 2258376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychopharmacologic treatment of pediatric anxiety disorders.
    Reinblatt SP; Walkup JT
    Child Adolesc Psychiatr Clin N Am; 2005 Oct; 14(4):877-908, x. PubMed ID: 16171707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Current status of treatment with benzodiazepines].
    Laux G
    Nervenarzt; 1995 May; 66(5):311-22. PubMed ID: 7609811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Consumption of benzodiazepines: good and bad uses].
    Ginestet D
    Encephale; 1983; 9(4 Suppl 2):97B-101B. PubMed ID: 6144536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Psychotropic drugs in general practice].
    Zimmer A
    Praxis (Bern 1994); 2014 Jun; 103(13):763-6. PubMed ID: 24938158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alprazolam (Xanax, and others) revisited.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):5-7. PubMed ID: 15647704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Animal models of anxiety: are they suitable for predicting drug action in humans?
    Bourin M
    Pol J Pharmacol; 1997; 49(2-3):79-84. PubMed ID: 9437753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benzodiazepine derivatives--side effects and dangers.
    Lader MH; Petursson H
    Biol Psychiatry; 1981 Dec; 16(12):1195-201. PubMed ID: 6130800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Proper and improper use of benzodiazepines].
    Gorwood P; Lejoyeux M
    Rev Prat; 1994 Nov; 44(17):2320-3. PubMed ID: 7984940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Panic disorder].
    Heinzl S
    Med Monatsschr Pharm; 1996 Mar; 19(3):79-80. PubMed ID: 8868966
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term use of benzodiazepines.
    Postgrad Med; 1990 Jun; 87(8):31, 34. PubMed ID: 1971718
    [No Abstract]   [Full Text] [Related]  

  • 58. Benzodiazepines and the treatment of anxiety disorders in patients with comorbid alcohol and/or drug abuse.
    Sher L
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170-1. PubMed ID: 18354817
    [No Abstract]   [Full Text] [Related]  

  • 59. A risk-benefit assessment of buspirone in the treatment of anxiety disorders.
    Pecknold JC
    Drug Saf; 1997 Feb; 16(2):118-32. PubMed ID: 9067123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.